[Use of adrenergic alpha receptor blockaders in patients with myocardial infarct in the state of shock].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D010276:Parasympatholytics / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology; D013565:Sympatholytics / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D003911:Dextrans; D010276:Parasympatholytics; D013565:Sympatholytics; D002746:Chlorpromazine
Primenenie blokatora adrenergicheskikh alpha-retseptorov u bol'nykh infarktom miokarda v sostoianii shoka.